# Effect of Zilretta Injection

> **NCT04261049** · PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 35 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** Triamcinolone Acetonide Extended-Release Injectable Suspension

## Key facts

- **NCT ID:** NCT04261049
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2022-01-10
- **Final completion:** 2022-01-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2022-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04261049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04261049, "Effect of Zilretta Injection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04261049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*